A Roadmap For Immunotherapy Success In Oncology
6 comments | February 21, 2012 |
includes:
AMGN, BMY, CELG, DNDN, GALE, GSK, IMUC.OB, MRK, NVS, ONTY
.....According to Henry Gosebruch, managing director of health-care mergers and acquisitions at J.P. Morgan, analysts at the firm expect the following:
"The large biotechs (will look) to be active acquirers in 2012.
Investors have rewarded strategic acquisitions that enhance long-term growth and companies that continue their history of developing innovative therapies, as opposed to turning into dividend-paying, share-repurchase type low-growth stocks."
The above sentiment is further supported by a report from Bloomberg, which showcased how biotech companies have historically been less active than their pharmaceutical industry counterparts regarding M&A activity.
For example, over the past 4 years, Bristol-Myers Squibb (BMY) has completed an impressive 17 acquisitions, while biotech industry heavyweight, Celgene (CELG), has completed a mere 3 acquisitions.....
http://seekingalpha.com/article/379931-a-roadmap-for-immunotherapy-success-in-oncology?source=yahoo
- Forums
- ASX - By Stock
- IMM
- immunotherapy based biotechs into 2012
immunotherapy based biotechs into 2012, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M |
Open | High | Low | Value | Volume |
39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 127863 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 30850 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2700 | 0.405 |
4 | 77500 | 0.400 |
5 | 89711 | 0.395 |
9 | 535780 | 0.390 |
8 | 278921 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 15972 | 1 |
0.430 | 114810 | 6 |
0.435 | 47564 | 2 |
0.440 | 51000 | 4 |
0.445 | 11000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online